Multimorbidity and Frailty: Tackling Complexity in Parkinson's Disease

Research output: Contribution to journalReview article (Academic Journal)

Abstract

Parkinson's disease (PD) is a condition that predominantly affects older people. It is imperative that clinical management considers the other significant illnesses that people with PD accumulate as they age in conjunction with their resilience to cope with physiological change. Multimorbidity and frailty act synergistically to heighten the risk of adverse outcomes for older people with PD. These states are associated with increased likelihood of hospitalisation, polypharmacy, adverse drug effects including the anticholinergic burden of medications, drug-disease and drug-drug interactions. Management should be integrated, holistic and individualised to meticulously balance the risks of interventions considering the vulnerability of the individual to recover from disturbance to their environmental, physical and cognitive equilibrium.

Original languageEnglish
JournalJournal of Parkinson's Disease
Early online date29 Jul 2020
DOIs
Publication statusE-pub ahead of print - 29 Jul 2020

Fingerprint Dive into the research topics of 'Multimorbidity and Frailty: Tackling Complexity in Parkinson's Disease'. Together they form a unique fingerprint.

  • Cite this